Summary Summary Short summary of a recent publication, written by scientific experts.
Nucleus basalis of Meynert deep brain stimulation (NBM-DBS) for Lewy body dementia (LBD) was well tolerated but resulted in decreased cognitive function, with no significant improvement in cognitive or behavioral status at 3 months, and increased brain occipital metabolic activity.
Preliminary studies had indicated that NBM-DBS may be a new therapeutic option in patients with LBD, however more studies were needed to assess safety and potential therapeutic effects.
International Medical Press is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.
No responsibility is assumed by International Medical Press for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, International Medical Press recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of International Medical Press or the sponsor. International Medical Press assumes no liability for any material contained herein.